When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Supernus Pharmaceuticals (NASDAQ:SUPN) is scheduled to announce Q1 earnings results on Monday, May 9th, after market close. The consensus EPS Estimate is $0.45 (+225.0% Y/Y) and the consensus Revenue Estimate is $150.47M (+679.2% Y/Y). Over the last 1 year, SUPN has beaten EPS estimates 75% of the time and has beaten revenue estimates 0% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.